Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32789489.
- Also identified by DOI 10.1001/jamaoncol.2020.3545 and PMC identifier 7426885.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study uses National Cancer Database data from 2004 to 2014 to examine the association between overall survival and timing of radiotherapy relative to androgen deprivation therapy in patients with prostate cancer.
Medical subject headings
- Androgen Antagonists
- Coronavirus Infections
- Pneumonia, Viral
- Prostatic Neoplasms